New research from the Garvan Institute of Medical Research and UNSW Sydney offers a clear biological explanation for the gender gap in autoimmune disease diagnosis. While autoimmune conditions such as lupus affect women at significantly higher rates than men, the precise genetic mechanics behind this disparity have historically remained obscure. By analyzing immune cells at a single-cell resolution, scientists have identified over 1,000 genetic switches that function differently depending on biological sex.
The study, published in The American Journal of Human Genetics, indicates that these differences are not concentrated on sex chromosomes as previously assumed. Instead, the majority of these genetic switches exist on autosomes, the non-sex chromosomes. In females, these switches appear to drive higher activity in inflammatory pathways. This heightened state of readiness provides a distinct advantage when fighting viral infections, yet it creates a biological trade-off. This immune hyper-reactivity increases the probability that the body will mistakenly target its own tissues, leading to autoimmune triggers.
Historically, medical research has relied heavily on male-centric study groups, which limits the current understanding of how diseases manifest across genders. This research involved nearly 1,000 healthy participants from the OneK1K cohort to map out immune cell behavior. The team sequenced over 1.25 million peripheral blood mononuclear cells to capture this level of detail. The findings demonstrate that male immune systems tend to be less primed for inflammation, which leaves men more susceptible to infections and specific cancers but less prone to the immune self-attacks that characterize lupus and other conditions.
These findings suggest that the clinical approach to autoimmune management requires an update. Standard treatments often involve broad immunosuppression, which may not account for the baseline genetic differences in immune operation. By identifying these specific pathways, the research supports a shift toward precision medicine. Tailoring treatments based on how a patient's immune system operates at a genetic level could improve outcomes for those managing long-term conditions. The researchers advocate for inclusive study designs that prioritize sex-based biological data to ensure medical treatments are effective for all patients.